Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?
- DOI
- 10.5414/alx02460e
- Published
- 2024-01-01
- Container
- Allergologie select
- Publisher
- Dustri-Verlgag Dr. Karl Feistle
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.5414/alx02460e,
title = {Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?},
author = {Ludger Klimek and Ulrike Förster-Ruhrmann and Heidi Olze and Achim G. Beule and Adam M. Chaker and Jan Hagemann and Tilman Huppertz and Thomas K. Hoffmann and Stefan Dazert and Thomas Deitmer and Sebastian Strieth and Holger Wrede and Wolfgang W. Schlenter and Hans-Jürgen Welkoborsky and Barbara Wollenberg and Sven Becker and Fredericke Bärhold and Felix Klimek and Ingrid Casper and Jaron Zuberbier and Claudia Rudack and Mandy Cuevas and Constantin A. Hintschich and Orlando Guntinas-Lichius and Timo Stöver and Christoph Bergmann and Pascal Werminghaus and Oliver Pfaar and Jan Gosepath and Moritz Gröger and Caroline Beutner and Martin Laudien and Rainer K. Weber and Tanja Hildenbrand and Anna S. Hoffmann and Claus Bachert},
year = {2024},
journal = {Allergologie select},
doi = {10.5414/alx02460e},
url = {https://doi.org/10.5414/alx02460e}
}RIS
TY - JOUR TI - Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy? AU - Ludger Klimek AU - Ulrike Förster-Ruhrmann AU - Heidi Olze AU - Achim G. Beule AU - Adam M. Chaker AU - Jan Hagemann AU - Tilman Huppertz AU - Thomas K. Hoffmann AU - Stefan Dazert AU - Thomas Deitmer AU - Sebastian Strieth AU - Holger Wrede AU - Wolfgang W. Schlenter AU - Hans-Jürgen Welkoborsky AU - Barbara Wollenberg AU - Sven Becker AU - Fredericke Bärhold AU - Felix Klimek AU - Ingrid Casper AU - Jaron Zuberbier AU - Claudia Rudack AU - Mandy Cuevas AU - Constantin A. Hintschich AU - Orlando Guntinas-Lichius AU - Timo Stöver AU - Christoph Bergmann AU - Pascal Werminghaus AU - Oliver Pfaar AU - Jan Gosepath AU - Moritz Gröger AU - Caroline Beutner AU - Martin Laudien AU - Rainer K. Weber AU - Tanja Hildenbrand AU - Anna S. Hoffmann AU - Claus Bachert PY - 2024 JO - Allergologie select DO - 10.5414/alx02460e UR - https://doi.org/10.5414/alx02460e ER -
APA
Klimek, L., Förster-Ruhrmann, U., Olze, H., Beule, A. G., Chaker, A. M., Hagemann, J., Huppertz, T., Hoffmann, T. K., Dazert, S., Deitmer, T., Strieth, S., Wrede, H., Schlenter, W. W., Welkoborsky, H., Wollenberg, B., Becker, S., Bärhold, F., Klimek, F., Casper, I., Zuberbier, J., Rudack, C., Cuevas, M., Hintschich, C. A., Guntinas-Lichius, O., Stöver, T., Bergmann, C., Werminghaus, P., Pfaar, O., Gosepath, J., Gröger, M., Beutner, C., Laudien, M., Weber, R. K., Hildenbrand, T., Hoffmann, A. S., & Bachert, C. (2024). Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?. Allergologie select. https://doi.org/10.5414/alx02460e
Source records
- crossref · retrieved 2026-09-26T06:20:38.240Z